Schedule 13D ownership disclosure

REPARE THERAPEUTICS INC

Common Shares · CUSIP: 760273102

Event date: 2025-11-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Versant Venture Capital V, L.P.Reported CIK 0001589097

    Shares: 0 · Class: 0.0%

  • Versant Affiliates Fund V, L.P.Reported CIK 0001589095

    Shares: 2,693 · Class: 0.0%

  • Versant Ophthalmic Affiliates I, L.P.Reported CIK 0001589098

    Shares: 2,982 · Class: 0.0%

  • Versant Ventures V, LLCReported CIK 0001619298

    Shares: 5,675 · Class: 0.0%

  • Versant Venture Capital V (Canada) LPReported CIK 0001612235

    Shares: 6,814 · Class: 0.0%

  • Versant Ventures V (Canada), L.P.Reported CIK 0001716490

    Shares: 6,814 · Class: 0.0%

  • Versant Ventures V GP-GP (Canada), Inc.Reported CIK 0001619297

    Shares: 6,814 · Class: 0.0%

  • Versant Venture Capital VI, L.P.Reported CIK 0001687880

    Shares: 0 · Class: 0.0%

  • Versant Ventures VI GP, L.P.Reported CIK 0001777654

    Shares: 0 · Class: 0.0%

  • Versant Ventures VI GP-GP, LLCReported CIK 0001777652

    Shares: 0 · Class: 0.0%

  • Versant Vantage I, L.P.Reported CIK 0001765253

    Shares: 72,211 · Class: 0.2%

  • Versant Vantage I GP, L.P.Reported CIK 0001777651

    Shares: 72,211 · Class: 0.2%

  • Versant Vantage I GP-GP, LLCReported CIK 0001777653

    Shares: 72,211 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-291733
Form type
SCHEDULE 13D/A
Filer
Repare Therapeutics Inc.
CIK
CIK 1808158
Filed
Nov 21, 2025
Reporting period
Nov 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub